serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease血清脂肪酸结合蛋白4是一个预测心血管疾病的终末期肾病.pdfVIP

serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease血清脂肪酸结合蛋白4是一个预测心血管疾病的终末期肾病.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease血清脂肪酸结合蛋白4是一个预测心血管疾病的终末期肾病

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease 1 1 1 2 3 Masato Furuhashi *, Shutaro Ishimura , Hideki Ota , Manabu Hayashi , Takahiro Nishitani , Marenao 1 1 4 ¨ 5 1 Tanaka , Hideaki Yoshida , Kazuaki Shimamoto , Gokhan S. Hotamisligil , Tetsuji Miura 1 Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan, 2 Second Department of Internal Medicine, Obihiro Kosei Hospital, Obihiro, Japan, 3 Obihiro East Medical and Cardiovascular Clinic, Obihiro, Japan, 4 Sapporo Medical University, Sapporo, Japan, 5 Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America Abstract Background: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both adipocytes and macrophages. Recent studies have shown that FABP4 is secreted from adipocytes and that FABP4 level is associated with obesity, insulin resistance, and atherosclerosis. However, little is known about the impact of FABP4 concentrations on prognosis. We tested the hypothesis that FABP4 level predicts prognosis of patients with end-stage renal disease (ESRD), a group at high risk for atherosclerosis-associated morbidity and mortality. Methods and Results: Biochemical markers including FABP4 were determined in 61 ESRD patients on chronic hemodialysis (HD). Serum FABP4 level in females (404.2630.5 ng/ml) was significantly higher than that in males (315.8 630.0 ng/ml), and the levels in ESRD patients were about 20-times higher than those in age-, gender- and body m

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档